Health
SARS-CoV-2 can disrupt the blood-brain barrier, find scientists – Drug Target Review
Binding of SARS-CoV-2 spike proteins to the brain’s endothelial cells could be the cause the neurological symptoms associated with COVID-19.
Posted: 2 November 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Binding of SARS-CoV-2 spike proteins to the brains endothelial cells can cause the blood-brain barrier to become leaky, potentially causing the neurological symptoms associated with COVID-19.
While the causes of respiratory symptoms related to SARS-CoV-2 infection have been well studied, the vascular and neurological symptoms are more poorly understood.
In the case of respiratory symptoms, it is known that entry of the…
-
General23 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre
-
General21 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General13 hours agoPope Francis makes surprise first appearance after hospital stay
-
General20 hours agoDonald Trump and the ghost of Al Capone • Inside Story